The prevalence of overtreatment of osteoporosis: results from the PAADRN trial

ConclusionIn our sample of older adults, overuse of osteoporosis pharmacotherapy was only 8.1%. Nevertheless, overtreatment exposes patients to possible risk with negligible chance of benefit and should be minimized.Trial registrationclinicaltrials.gov identifier: NCT01507662
Source: Archives of Orthopaedic and Trauma Surgery - Category: Orthopaedics Source Type: research